drugset / Trial / NCT07030101
A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study if to evaluate the efficacy and safety of TCA108 on treatment of hypertension.
Timeline
- Start
- 2026-11
- Primary completion
- 2029-05
- Completion
- 2029-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bramicar HCT | Unknown | — | — |
| Comparator | Micardis Anlo | Unknown | — | — |
| Subject | TCA108 | Unknown | — | — |